OPRA
Opera Limited
OPRA has a slight edge over TMUS overall, supported by stronger fundamentals.
TMUS
T-Mobile US, Inc.
TMUS has lower modeled downside risk, despite its lower overall score.
OPRA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Strong |
OPRA's revenue, profitability, cash flow and balance sheet are all currently healthy.
TMUS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
TMUS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
OPRA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.4x | $10.24 | -35% |
| Current | 11x | $15.63 | — |
| Fair | 16x | $22.42 | +43% |
| Expensive | 28x | $38.34 | +145% |
Historical ranges are pointers, not guarantees.
OPRA's PE is in its cheap range at 11x, but its recent earnings include one-off gains.
TMUS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $171 | — |
| Current | 16x | $171 | — |
| Cheap | 21x | $218 | +27% |
| Fair | 26x | $274 | +60% |
| Expensive | 56x | $581 | +240% |
Historical ranges are pointers, not guarantees.
TMUS has the edge over OPRA in the historical PE scenario, which offers more potential upside but is not a forecast.
OPRA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for OPRA, with profitability improving.
TMUS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for TMUS, with profitability improving.
OPRA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $1.38 | +55% |
| Q1 2026 | $1.25 | +33% |
| Q4 2025 | $1.18 | +30% |
| Q4 2025 | $0.89 | -55% |
| Q2 2025 | $0.89 | -54% |
| Q1 2025 | $0.94 | -50% |
| Q4 2024 | $0.91 | -52% |
| Q3 2024 | $1.97 | +170% |
OPRA's earnings per share have fallen from their peak: $1.38 over the past year, against $1.97 in late 2024. Its recent earnings include one-off gains.
TMUS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.49 | +30% |
| Q3 2026 | $10.37 | -0.2% |
| Q2 2026 | $9.56 | -9.7% |
| Q1 2026 | $9.41 | -8.1% |
| Q4 2025 | $9.72 | +0.6% |
| Q3 2025 | $10.39 | +18% |
| Q2 2025 | $10.59 | +33% |
| Q1 2025 | $10.24 | +39% |
| Q4 2024 | $9.66 | +39% |
TMUS has the edge over OPRA on earnings, with more consistent year-over-year improvement.
OPRA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $177.5M | +24% |
| Q1 2026 | $175.8M | +23% |
| Q4 2025 | $177M | +21% |
| Q4 2025 | $151.9M | +23% |
| Q2 2025 | $143M | +30% |
| Q1 2025 | $142.7M | +40% |
| Q4 2024 | $145.8M | +29% |
| Q3 2024 | $123.2M | +20% |
OPRA has the edge over TMUS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 16% | +3.7 points |
| Q1 2026 | 17% | +2.5 points |
| Q4 2025 | 17% | -2.3 points |
| Q4 2025 | 15% | -4.1 points |
| Q2 2025 | 13% | -7.3 points |
| Q1 2025 | 15% | -4.4 points |
| Q4 2024 | 19% | +0.9 points |
| Q3 2024 | 19% | +3.2 points |
OPRA's operating margin was 16% last quarter, up 3.7 points from the same quarter a year ago.
TMUS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.6B | +7.4% |
| Q2 2026 | $22.8B | +7.9% |
| Q1 2026 | $23.1B | +11% |
| Q4 2025 | $24.3B | +11% |
| Q3 2025 | $22B | +8.9% |
| Q2 2025 | $21.1B | +6.9% |
| Q1 2025 | $20.9B | +6.6% |
| Q4 2024 | $21.9B | +6.8% |
TMUS's revenue has grown year over year for 10 quarters in a row: $23.6B last quarter, up 7.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | +3.4 points |
| Q2 2026 | 24% | -0.6 points |
| Q1 2026 | 19% | -3.5 points |
| Q4 2025 | 15% | -5.6 points |
| Q3 2025 | 21% | -3.2 points |
| Q2 2025 | 25% | +1.3 points |
| Q1 2025 | 23% | +2.6 points |
| Q4 2024 | 21% | +4 points |
TMUS has the edge over OPRA on profitability, with a higher operating margin.
OPRA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $21.8M | -28% |
| Q1 2026 | $36.8M | +140% |
| Q4 2025 | $39.6M | +101% |
| Q4 2025 | $22.5M | -27% |
| Q2 2025 | $30.3M | +109% |
| Q1 2025 | $15.3M | +42% |
| Q4 2024 | $19.7M | -20% |
| Q3 2024 | $30.8M | +93% |
OPRA generated $121M in free cash flow over the past year, up 26% from the year before.
TMUS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +5.3% |
| Q2 2026 | $4.8B | +4.4% |
| Q1 2026 | $4.6B | +4.6% |
| Q4 2025 | $4.2B | +25% |
| Q3 2025 | $4.8B | +15% |
| Q2 2025 | $4.6B | +32% |
| Q1 2025 | $4.4B | +79% |
| Q4 2024 | $3.3B | +2% |
TMUS generated $18.7B in free cash flow over the past year, up 8.8% from the year before.
OPRA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -67K shares |
| 1 year | +0.8% | +760K shares |
| 3 years | -0.3% | -237K shares |
| 5 years | -21% | -24.7M shares |
| Available history | -19% | -21.9M shares |
OPRA has 91M diluted shares, up 0.8% from a year ago, despite $27M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $14.2M |
| Q1 2026 | $12.8M |
| Q4 2025 | — |
| Q4 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
OPRA spent $27M buying back its own shares over the past year, after none the year before.
TMUS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -10.8M shares |
| 1 year | -4.9% | -55M shares |
| 3 years | -8.8% | -103M shares |
| 5 years | -15% | -182M shares |
| Available history | +24% | +207M shares |
TMUS has the edge over OPRA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.4B |
| Q2 2026 | $2.3B |
| Q1 2026 | $4.8B |
| Q4 2025 | $2.4B |
| Q3 2025 | $2.5B |
| Q2 2025 | $2.6B |
| Q1 2025 | $2.5B |
| Q4 2024 | $4.7B |
TMUS spent $12B buying back its own shares over the past year, down 1.7% from the year before.
OPRA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -0.8x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
| Q3 2024 | -1.0x | Net Cash |
OPRA has the edge over TMUS on leverage, with a lower net debt burden relative to earnings.
TMUS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | 2.5x | Moderate |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 2.4x | Moderate |
TMUS's net debt is less than a year of its operating earnings (EBITDA).
OPRA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 9.3 | Oversold |
OPRA's weekly RSI is 40 (neutral) and its Stochastic is 9 (oversold).
TMUS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.9 | Neutral |
| Stochastic | 42.1 | Neutral |
TMUS's weekly RSI is 48 (neutral) and its Stochastic is 42 (neutral).
OPRA PE vs Communication Services Sector
| Metric | OPRA | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 16x | 31% below |
| PE % | 25 | 26 | 1 pt below |
OPRA has the edge over TMUS on valuation relative to its sector.
TMUS PE vs Communication Services Sector
| Metric | TMUS | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 16x | Same PE |
| PE % | 1 | 26 | 25 pts below |
TMUS is trading at 16x earnings, in line with the Communication Services sector's median of 16x.
OPRA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $16.7 | 6.6% below |
| 20 week MA | $18.2 | 14% below |
| 50 week MA | $16.6 | 5.6% below |
| 100 week MA | $16.9 | 7.6% below |
| 200 week MA | $15.3 | 2.4% above |
OPRA has fallen below most of its moving averages, though it's still 2.4% above its 200-week average.
TMUS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $159.1 | 7.5% above |
| 20 week MA | $172.0 | 0.5% below |
| 50 week MA | $187.8 | 8.9% below |
| 100 week MA | $212.9 | 20% below |
| 200 week MA | $188.7 | 9.4% below |
TMUS has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 9.4% below its 200-week average.
OPRA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.44 | $8.49 | -10% |
| 2021 | $8.49 | $7.19 | -15% |
| 2022 | $7.19 | $5.98 | -17% |
| 2023 | $5.98 | $13.2 | +121% |
| 2024 | $13.2 | $19.0 | +43% |
| 2025 | $19.0 | $14.5 | -24% |
| 2026 YTD | $14.5 | $15.6 | +7.7% |
OPRA has the edge over TMUS on returns for 2026, with the stronger performance.
TMUS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $77.2 | $132.9 | +72% |
| 2021 | $132.9 | $119.9 | -9.8% |
| 2022 | $119.9 | $140.0 | +17% |
| 2023 | $140.0 | $160.3 | +15% |
| 2024 | $160.3 | $223.0 | +39% |
| 2025 | $223.0 | $201.0 | -9.9% |
| 2026 YTD | $201.0 | $171.0 | -15% |
TMUS has finished higher in four of the last six years. It's down 15% so far in 2026.